175 related articles for article (PubMed ID: 37263082)
1. MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view.
Natalicchio A; Montagnani M; Gallo M; Marrano N; Faggiano A; Zatelli MC; Mazzilli R; Argentiero A; Danesi R; D'Oronzo S; Fogli S; Giuffrida D; Gori S; Ragni A; Renzelli V; Russo A; Franchina T; Tuveri E; Sciacca L; Monami M; Cirino G; Di Cianni G; Colao A; Avogaro A; Cinieri S; Silvestris N; Giorgino F
ESMO Open; 2023 Jun; 8(3):101573. PubMed ID: 37263082
[TBL] [Abstract][Full Text] [Related]
2. Endocrine-metabolic assessment checklist for cancer patients treated with immunotherapy: A proposal by the Italian Association of Medical Oncology (AIOM), Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology (SIE) and Italian Society of Pharmacology (SIF) multidisciplinary group.
Zatelli MC; Faggiano A; Argentiero A; Danesi R; D'Oronzo S; Fogli S; Franchina T; Giorgino F; Marrano N; Giuffrida D; Gori S; Marino G; Mazzilli R; Monami M; Montagnani M; Morviducci L; Natalicchio A; Ragni A; Renzelli V; Russo A; Sciacca L; Tuveri E; Aimaretti G; Avogaro A; Candido R; Di Maio M; Silvestris N; Gallo M
Cancer Treat Rev; 2024 May; 126():102734. PubMed ID: 38604051
[TBL] [Abstract][Full Text] [Related]
3. Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper.
Natalicchio A; Faggiano A; Zatelli MC; Argentiero A; D'Oronzo S; Marrano N; Beretta GD; Acquati S; Adinolfi V; Di Bartolo P; Danesi R; Ferrari P; Gori S; Morviducci L; Russo A; Tuveri E; Montagnani M; Gallo M; Silvestris N; Giorgino F
Crit Rev Oncol Hematol; 2022 Jan; 169():103572. PubMed ID: 34954047
[TBL] [Abstract][Full Text] [Related]
4. Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer.
Renzelli V; Gallo M; Morviducci L; Marino G; Ragni A; Tuveri E; Faggiano A; Mazzilli R; Natalicchio A; Zatelli MC; Montagnani M; Fogli S; Giuffrida D; Argentiero A; Danesi R; D'Oronzo S; Gori S; Franchina T; Russo A; Monami M; Sciacca L; Cinieri S; Colao A; Avogaro A; Di Cianni G; Giorgino F; Silvestris N
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686512
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids in oncology: Use, overuse, indications, contraindications. An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper.
Faggiano A; Mazzilli R; Natalicchio A; Adinolfi V; Argentiero A; Danesi R; D'Oronzo S; Fogli S; Gallo M; Giuffrida D; Gori S; Montagnani M; Ragni A; Renzelli V; Russo A; Silvestris N; Franchina T; Tuveri E; Cinieri S; Colao A; Giorgino F; Zatelli MC;
Crit Rev Oncol Hematol; 2022 Dec; 180():103826. PubMed ID: 36191821
[TBL] [Abstract][Full Text] [Related]
6. Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper.
Silvestris N; Franchina T; Gallo M; Argentiero A; Avogaro A; Cirino G; Colao A; Danesi R; Di Cianni G; D'Oronzo S; Faggiano A; Fogli S; Giuffrida D; Gori S; Marrano N; Mazzilli R; Monami M; Montagnani M; Morviducci L; Natalicchio A; Ragni A; Renzelli V; Russo A; Sciacca L; Tuveri E; Zatelli MC; Giorgino F; Cinieri S
ESMO Open; 2023 Dec; 8(6):102062. PubMed ID: 38070434
[TBL] [Abstract][Full Text] [Related]
7. Early prediction of pancreatic cancer from new-onset diabetes: an Associazione Italiana Oncologia Medica (AIOM)/Associazione Medici Diabetologi (AMD)/Società Italiana Endocrinologia (SIE)/Società Italiana Farmacologia (SIF) multidisciplinary consensus position paper.
Gallo M; Adinolfi V; Morviducci L; Acquati S; Tuveri E; Ferrari P; Zatelli MC; Faggiano A; Argentiero A; Natalicchio A; D'Oronzo S; Danesi R; Gori S; Russo A; Montagnani M; Beretta GD; Di Bartolo P; Silvestris N; Giorgino F
ESMO Open; 2021 Jun; 6(3):100155. PubMed ID: 34020401
[TBL] [Abstract][Full Text] [Related]
8. Consensus report of the joint workshop of the Italian Society of Diabetology, Italian Society of Periodontology and Implantology, Italian Association of Clinical Diabetologists (SID-SIdP-AMD).
Adda G; Aimetti M; Citterio F; Consoli A; Di Bartolo P; Landi L; Lione L; Luzi L
Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2515-2525. PubMed ID: 34238654
[TBL] [Abstract][Full Text] [Related]
9. Bone fragility in patients with diabetes mellitus: A consensus statement from the working group of the Italian Diabetes Society (SID), Italian Society of Endocrinology (SIE), Italian Society of Gerontology and Geriatrics (SIGG), Italian Society of Orthopaedics and Traumatology (SIOT).
Napoli N; Incalzi RA; De Gennaro G; Marcocci C; Marfella R; Papalia R; Purrello F; Ruggiero C; Tarantino U; Tramontana F; Conte C
Nutr Metab Cardiovasc Dis; 2021 May; 31(5):1375-1390. PubMed ID: 33812734
[TBL] [Abstract][Full Text] [Related]
10. Commentary from the Italian Association of Medical Diabetologists (AMD) and Italian Society of Diabetology (SID) Interassociative Diabetes and Pregnancy Study Group on the screening and diagnostic methods for gestational diabetes: An open debate.
Bianchi C; Resi V; Manicardi E; Burlina S; Sculli MA; Formoso G; Sciacca L
Nutr Metab Cardiovasc Dis; 2023 Nov; 33(11):2102-2106. PubMed ID: 37684171
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs in the pathogenesis of type 2 diabetes: new research progress and future direction.
Miao C; Zhang G; Xie Z; Chang J
Can J Physiol Pharmacol; 2018 Feb; 96(2):103-112. PubMed ID: 28898588
[TBL] [Abstract][Full Text] [Related]
12. Diabetic ketoacidosis: A consensus statement of the Italian Association of Medical Diabetologists (AMD), Italian Society of Diabetology (SID), Italian Society of Endocrinology and Pediatric Diabetoloy (SIEDP).
Lapolla A; Amaro F; Bruttomesso D; Di Bartolo P; Grassi G; Maffeis C; Purrello F; Tumini S
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1633-1644. PubMed ID: 32771260
[TBL] [Abstract][Full Text] [Related]
13. The miRNA profile of human pancreatic islets and beta-cells and relationship to type 2 diabetes pathogenesis.
van de Bunt M; Gaulton KJ; Parts L; Moran I; Johnson PR; Lindgren CM; Ferrer J; Gloyn AL; McCarthy MI
PLoS One; 2013; 8(1):e55272. PubMed ID: 23372846
[TBL] [Abstract][Full Text] [Related]
14. Effects of polyphenols on cardio-metabolic risk factors and risk of type 2 diabetes. A joint position statement of the Diabetes and Nutrition Study Group of the Italian Society of Diabetology (SID), the Italian Association of Dietetics and Clinical Nutrition (ADI) and the Italian Association of Medical Diabetologists (AMD).
Giacco R; Costabile G; Fatati G; Frittitta L; Maiorino MI; Marelli G; Parillo M; Pistis D; Tubili C; Vetrani C; Vitale M
Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):355-367. PubMed ID: 31918979
[TBL] [Abstract][Full Text] [Related]
15. Targeting miRNA for Therapy of Juvenile and Adult Diabetic Cardiomyopathy.
Nandi SS; Mishra PK
Adv Exp Med Biol; 2018; 1056():47-59. PubMed ID: 29754174
[TBL] [Abstract][Full Text] [Related]
16. Involvement of MicroRNAs in Diabetes and Its Complications.
Wu B; Miller D
Methods Mol Biol; 2017; 1617():225-239. PubMed ID: 28540689
[TBL] [Abstract][Full Text] [Related]
17. Regulation of microRNAs in Alzheimer´s disease, type 2 diabetes, and aerobic exercise training.
De Sousa RAL; Improta-Caria AC
Metab Brain Dis; 2022 Mar; 37(3):559-580. PubMed ID: 35075500
[TBL] [Abstract][Full Text] [Related]
18. Decreased expression of microRNAs targeting type-2 diabetes susceptibility genes in peripheral blood of patients and predisposed individuals.
Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Sideris DC; Fragoulis EG; Christodoulou MI
Endocrine; 2019 Nov; 66(2):226-239. PubMed ID: 31559537
[TBL] [Abstract][Full Text] [Related]
19. Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus.
Hashimoto N; Tanaka T
J Hum Genet; 2017 Feb; 62(2):141-150. PubMed ID: 27928162
[TBL] [Abstract][Full Text] [Related]
20. The involvement of microRNAs in Type 2 diabetes.
Ferland-McCollough D; Ozanne SE; Siddle K; Willis AE; Bushell M
Biochem Soc Trans; 2010 Dec; 38(6):1565-70. PubMed ID: 21118127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
